
Pfizer Seeks Emergency Authorization for Covid-19 Treatment Pill
By Jamari Stanton, Opinions Editor Pfizer submitted its application to the Food and Drug Administration for emergency authorization of its antiviral Covid-19 pill, on Tuesday, November 16. At a time when Covid-19 is ravaging the world, this drug could revolutionize the fight. The pill, Paxlovid, could be available within weeks if authorized and would be…